Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing?
Fiche du document
- doi: 10.1002/dta.2790
- issn: 1942-7603
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1002/dta.2790
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32180361
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1942-7611
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BFDC37EC91FE1
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Pastimes Field sports Recreations AthleticsCiter ce document
M. Thevis et al., « Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? », Serveur académique Lausannois, ID : 10.1002/dta.2790
Métriques
Partage / Export
Résumé
Dried blood spots (DBS) have been considered as complementary matrix in sports drug testing for many years. Especially concerning substances prohibited in-competition only, the added value of DBS collected concomitantly with routine doping control urine samples has been debated, and an increasing potential of DBS has been discussed in the scientific literature. To which extent and under which prerequisites DBS can contribute to enhanced anti-doping efforts is currently evaluated. As a proof-of-principle, two analytical applications, one targeting cocaine/benzoyl ecgonine and the other prednisone/prednisolone, are presented in this perspective to indicate potential added value but also presently existing limitations of the DBS approach.